Indole derivatives as CRTH2 receptor antagonists

Details for Australian Patent Application No. 2009295229 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Wang, Zhaoyin

Agent Spruson & Ferguson

Pub. Number AU-A-2009295229

PCT Pub. Number WO2010/031182

Priority 61/192,786 22.09.08 US; 61/109,263 29.10.08 US

Filing date 17 September 2009

Wipo publication date 25 March 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/031182 Priority application(s): WO2010/031182

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009295230-Indole derivatives as CRTH2 receptor antagonists

2009295227-A method and device for reducing muscle tension through electrical manipulation